LAUREN GLICK: Open Payments
NPI 1366085482 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,792 in 136 payments from 19 companies in 2025. Trend: 2023 $1,200 · 2024 $2,587 · 2025 $3,792
Food & beverage: $3,002Consulting: $700Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 48 | $949 |
| Botanix SB Inc | 3 | $723 |
| Galderma Laboratories, L.P. | 17 | $562 |
| ABBVIE INC. | 23 | $452 |
| Novartis Pharmaceuticals Corporation | 7 | $262 |
| Regeneron Healthcare Solutions, Inc. | 12 | $231 |
| PFIZER INC. | 6 | $182 |
| GENZYME CORPORATION | 2 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $49 |
Products named: TREMFYA, SOFDRA, NEMLUVIO, SKYRIZI, DUPIXENT, LITFULO, CIBINQO, RINVOQ.
Industry payments across FL — which companies pay providers there.
